Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 20 2 2019
medline: 10 1 2020
entrez: 20 2 2019
Statut: ppublish

Résumé

The kallikrein/kinin system, an intravascular biochemical pathway that includes several proteins involved in the contact activation system of coagulation, renin-angiotensin activation and inflammation, may or may not play a role in venous thromboembolism (VTE) occurrence. Within a large prospective population-based study in the United States, we conducted a nested case-cohort study to test the hypothesis that higher plasma levels of high molecular weight kininogen (HK) or prekallikrein are associated with greater VTE incidence. We related baseline enzyme-linked immunosorbent assay measures of HK and prekallikrein in 1993 to 1995 to incidence VTE of the lower extremity (

Identifiants

pubmed: 30780167
doi: 10.1055/s-0039-1678737
pmc: PMC6499653
mid: NIHMS1005758
doi:

Substances chimiques

Kininogen, High-Molecular-Weight 0
Prekallikrein 9055-02-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-843

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL059367
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None declared.

Références

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2245-50
pubmed: 10479669
Atherosclerosis. 2002 Apr;161(2):261-7
pubmed: 11888508
J Biol Chem. 2002 Sep 6;277(36):32677-82
pubmed: 12082110
Am J Med. 2002 Dec 1;113(8):636-42
pubmed: 12505113
Am J Med. 2004 Jul 1;117(1):19-25
pubmed: 15210384
Thromb Res. 2004;114(2):91-6
pubmed: 15306150
J Exp Med. 2005 Jul 18;202(2):271-81
pubmed: 16009717
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2959-65
pubmed: 17293494
Blood. 2008 Feb 1;111(3):1274-81
pubmed: 18000168
Am J Med. 2008 Mar;121(3):231-8
pubmed: 18328308
Blood. 1991 Feb 1;77(3):500-7
pubmed: 1846761
Am J Hum Genet. 2010 Apr 9;86(4):626-31
pubmed: 20303064
Biochimie. 2010 Nov;92(11):1568-79
pubmed: 20346387
Br J Haematol. 2010 Jun;149(6):824-33
pubmed: 20456358
Circulation. 2010 Nov 2;122(18):1854-61
pubmed: 20956210
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Blood. 2015 Jan 22;125(4):710-9
pubmed: 25339356
Thromb J. 2015 May 06;13:17
pubmed: 25949215
Am J Hematol. 2015 Nov;90(11):1047-51
pubmed: 26260105
Thromb Res. 2015 Oct;136(4):781-5
pubmed: 26337932
Thromb Haemost. 2015 Nov;114(5):910-9
pubmed: 26354877
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
J Thromb Haemost. 2016 Jan;14(1):28-39
pubmed: 26565070
J Thromb Haemost. 2016 Jan;14(1):83-8
pubmed: 26565658
J Thromb Haemost. 2016 Mar;14(3):427-37
pubmed: 26707513
Biomed Pharmacother. 2018 Sep;105:526-532
pubmed: 29885636
Biochemistry. 1985 Sep 24;24(20):5558-67
pubmed: 3935163
J Clin Invest. 1983 May;71(5):1477-89
pubmed: 6406551
Biometrics. 1994 Dec;50(4):1064-72
pubmed: 7786988

Auteurs

Aaron R Folsom (AR)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States.

Weihong Tang (W)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States.

Saonli Basu (S)

Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States.

Jeffrey R Misialek (JR)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States.

David Couper (D)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Susan R Heckbert (SR)

Department of Epidemiology, University of Washington, Seattle, Washington, United States.

Mary Cushman (M)

Department of Medicine, University of Vermont, Burlington, Vermont, United States.
Department of Pathology, University of Vermont, Burlington, Vermont, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH